Advisory Alpha, LLC Novartis Ag Transaction History

Advisory Alpha, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $16,550 - $20,019	-212 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$82.14 - $91.0 $17,413 - $19,292	212 New	212 $258,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $23,550 - $26,510	-291 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$70.67 - $99.01 $20,564 - $28,811	291 New	291 $25.6 Million
Q2 2019 Aug 16, 2019	SELL	$75.4 - $92.8 $16,663 - $20,508	-221 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$75.32 - $86.15 $16,645 - $19,039	221 New	221 $0

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Alpha, LLC with notifications on news.